Clinical Trials | May 26, 2026
Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy
A one-shot gene-editing cholesterol therapy could soon be a reality
A one-shot gene-editing cholesterol therapy could soon be a reality
The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
BMS is moving beyond conversational AI into what it describes as “agentic” systems
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
She brings extensive expertise in managing global and domestic procurement operations
New CE-marked algorithm for the Azurion platform delivers improved image quality with over 50% lower radiation dose compared to the lowest settings on ClarityIQ
The development comes as stroke remains one of the world’s biggest health threats
Baxfendy works in a fundamentally different way from current therapies
Subscribe To Our Newsletter & Stay Updated
